Skip to main content

Table 5 Studies excluded from analysis and their reasons for exclusion

From: The treatment of sarcoptic mange in wildlife: a systematic review

Treated species and reference

Reason for exclusion

Vicuna (Vicugna vicugna), Gomez-Puerta et al. [53]

No treatment outcomes are described

Giraffe (Giraffa reticulata), Alasaad et al. [54]

Although reportedly successful on a population level, the study failed to recapture treated individuals and monitor their response to treatment

Capybara (Hydrochoerus hydrochaeris), Bernal et al. [55]

No treatment outcomes are described

Agile wallaby (Macropus agilis), McLelland et al. [37]

Although reportedly successful on an individual level, no post-treatment monitoring period is described

Gorilla (Gorilla beringei beringei), Graczyk et al. [22]

Although reportedly successful on an individual level, the study fails to specify the duration of their post-treatment monitoring period

Iberian ibex (Capra pyrenaica), Pérez et al. [56]

Limited treatment outcomes are described and there is no post-treatment monitoring period

Gray wolf (Canis lupus), Schultz et al. [17]

Although reportedly successful on an individual level, the diagnosis of sarcoptic mange is not confirmed by skin scrapings

Wild ruminants, Yeruham et al. [16]

Although reportedly successful on a population level, the study fails to specify the duration of their post-treatment monitoring period

Koala (Phascolarctos cinereus), Brown et al. [40]

The study does not specify the number of animals treated or recovered

Koala, Barker [38]

Although reportedly successful on an individual level, no post-treatment monitoring period is described